Prescription Drug Costs: Can Increased Competition Restrain Prices?

This is the agenda for the webinar held on June 14, 2018, titled, "Prescription Drug Costs: Can Increased Competition Restrain Prices?"

Thursday, June 14, 2018

1:00 – 1:05 p.m. Welcome and Introductions

Mary Ella Payne, R.N., MSPH, acting president and chief executive officer, Alliance for Health Policy @allhealthpolicy

1:05 – 1:35 p.m. Panelist Opening Remarks

Robert Langreth, senior health reporter, Bloomberg News, @RobertLangreth
Dora Hughes, M.D., MPH, senior policy advisor, Sidley Austin LLP
Sameer Awsare, M.D., associate executive director, The Permanente Medical Group, Kaiser Permanente, @kpshare

1:35 – 2:15 p.m. Question and Answer Session

The Alliance for Health Policy gratefully acknowledges the support of the National Institute for Health Care Management (NIHCM) Foundation for this event

Jun24

past webinar

COVID-19 Webinar Series Session 20 - Tensions, Tradeoffs, and Takeaways: What’s at Stake for America 100 Days into the Pandemic  and Where We Go From Here

Just over 100 days have passed since the COVID-19 pandemic was declared a national emergency on March 13, 2020. The pandemic has led to sweeping ramifications throughout the American economy and society as a whole. During this interactive discussion, three preeminent health policy leaders examined the lessons learned three months into the crisis and lay out considerations for decision-makers as they work to stem the tide of the pandemic and build a more resilient health care system.

Learn More

Share